These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17291380)

  • 1. Secular trends in the epidemiology of shingles in Alberta.
    Russell ML; Schopflocher DP; Svenson L; Virani SN
    Epidemiol Infect; 2007 Aug; 135(6):908-13. PubMed ID: 17291380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shingles in Alberta: before and after publicly funded varicella vaccination.
    Russell ML; Dover DC; Simmonds KA; Svenson LW
    Vaccine; 2014 Oct; 32(47):6319-24. PubMed ID: 24099868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing epidemiology of chickenpox in Alberta.
    Russell ML; Svenson LW; Yiannakoulias N; Schopflocher DP; Virani SN; Grimsrud K
    Vaccine; 2005 Nov; 23(46-47):5398-403. PubMed ID: 15964104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of shingles vaccine among Albertans aged 50 years or older: A retrospective cohort study.
    McDonald BM; Dover DC; Simmonds KA; Bell CA; Svenson LW; Russell ML
    Vaccine; 2017 Dec; 35(50):6984-6989. PubMed ID: 29128385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program.
    Tanuseputro P; Zagorski B; Chan KJ; Kwong JC
    Vaccine; 2011 Nov; 29(47):8580-4. PubMed ID: 21939721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
    Lin YH; Huang LM; Chang IS; Tsai FY; Lu CY; Shao PL; Chang LY; ;
    Vaccine; 2010 Feb; 28(5):1217-20. PubMed ID: 19944790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health disparities in chickenpox or shingles in Alberta?
    Russell ML; Schopflocher DP; Svenson LW
    Can J Public Health; 2008; 99(1):41-5. PubMed ID: 18435390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, Canada.
    Liu XC; Simmonds KA; Russell ML; Svenson LW
    BMC Public Health; 2014 Oct; 14():1098. PubMed ID: 25342438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.
    Carville KS; Riddell MA; Kelly HA
    Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture.
    Toyama N; Shiraki K;
    J Med Virol; 2009 Dec; 81(12):2053-8. PubMed ID: 19856466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of motor neurone disease in the Province of Alberta.
    Svenson LW; Cwik VA; Martin WR
    Can J Neurol Sci; 1999 May; 26(2):119-22. PubMed ID: 10352871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008.
    Tseng HF; Smith N; Marcy SM; Sy LS; Jacobsen SJ
    Pediatr Infect Dis J; 2009 Dec; 28(12):1069-72. PubMed ID: 19773676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989-1998: identification of high risk groups.
    Long R; Sutherland K; Kunimoto D; Cowie R; Manfreda J
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):615-21. PubMed ID: 12102301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family history and herpes zoster risk in the era of shingles vaccination.
    Hernandez PO; Javed S; Mendoza N; Lapolla W; Hicks LD; Tyring SK
    J Clin Virol; 2011 Dec; 52(4):344-8. PubMed ID: 21924676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.